Lauxera Capital Partners
Growth equityParis · Growth–Late Stage · 16 people tracked
Investment thesis
Lauxera invests in healthtech businesses that have reached early profitability, aiming to catalyze inflections in growth through new innovation, commercial investment, business development, and stronger talent. The firm partners with founders and world-class managers, contributing both capital and operational expertise to improve the efficiency of the healthtech system, save lives, and reduce costs. Its team combines entrepreneurial company builders with experienced investors who have guided healthtech companies across all growth stages. Lauxera operates from offices in Europe and the United States and targets investment tickets ranging from roughly 20 to 100 million euros.
Source: firm website, verified Aug 11, 2026.
Team · 16 people
from the firm's websiteWhat they invest in
from 3 of 15 portfolio companiesHealthtech ×2Medical Devices ×2Biotech ×1Digital Health ×1FemTech ×1
HQs:United States×1
Investments · 15 tracked
founders shown can be your intro pathGerman neurovascular device company; a minority investment from Lauxera Growth II.
Swedish advanced imaging CRO; a majority investment from Lauxera Growth II.
HealthtechBoston, US
Filip Pintelon(Director)Werner Zoellner(Director)Paul Summerside(Director)Bjoern von Siemens(Executive Officer, Director)Timothy Lantz(Executive Officer)Dennis Kogan(Executive Officer, Director)
Purple fund portfolio company.
Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning.
Digital HealthFemTechMedical Devices
Frequently asked questions
- What stage does Lauxera Capital Partners invest at?
- Lauxera Capital Partners invests at the Growth, Late Stage stages.
- What is Lauxera Capital Partners's typical check size?
- Lauxera Capital Partners typically writes checks of $22M – $110M.
- What sectors does Lauxera Capital Partners focus on?
- Lauxera Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Lauxera Capital Partners located?
- Lauxera Capital Partners is headquartered in Paris, FR.
- Does Lauxera Capital Partners lead rounds?
- Yes, Lauxera Capital Partners leads investment rounds.
Media · Podcasts & interviews
featuring the teamSMART BOURSE - Marchés à thème(s) : Pierre Moustial (Lauxera Capital Partners)
B SMART · Pierre Moustial
Pierre Moustial (Lauxera Capital Partners) & Martial Descoutures (Oddo BHF): Le journal des Biotechs
Boursorama · Pierre Moustial
BE SMART - L'interview de Pierre Moustial (Lauxera Capital Partners) par Stéphane Soumier
B SMART · Pierre Moustial
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.




